Growth stocks

搜索文档
Apple: I Was Wrong In July; That's Why I'm Switching To Buy Today (NASDAQ:AAPL)
Seeking Alpha· 2025-09-26 23:29
During the journey of my career, I have gradually understood to be humble and to be aware of my mistakes and consequently admit them. Where I come from, they say, “If you don't work, you don't make mistakes,” but I don't mean to justifyHi there, and welcome to my profile.I’m a finance professional with over a decade of experience across global markets, with a deep focus on macroeconomic analysis, portfolio management, and equity research. I currently serve as a Senior Analyst at a European asset management ...
Apple: I Was Wrong In July; That's Why I'm Switching To Buy Today
Seeking Alpha· 2025-09-26 23:29
During the journey of my career, I have gradually understood to be humble and to be aware of my mistakes and consequently admit them. Where I come from, they say, “If you don't work, you don't make mistakes,” but I don't mean to justifyHi there, and welcome to my profile.I’m a finance professional with over a decade of experience across global markets, with a deep focus on macroeconomic analysis, portfolio management, and equity research. I currently serve as a Senior Analyst at a European asset management ...
Amgen Stock: MariTide’s Progress, Reassessment Of The Horizon Acquisition (NASDAQ:AMGN)
Seeking Alpha· 2025-09-25 10:10
I publish my best ideas and top coverage on the Growth Stock Forum . If you're interested in finding great growth stocks, with a focus on biotech, consider signing up. We focus on attractive risk/reward situations and track each of our portfolio and watchlist stocks closely. To receive e-mail notifications for my public articles and blogs, please click the follow button . And to go deeper, sign up to Growth Stock Forum.Amgen Inc. (NASDAQ: AMGN ) has not been a great performer in the last two years. The stoc ...
1 ETF to Buy Before the End of 2025
Yahoo Finance· 2025-09-22 11:13
Key Points This is a powerful growth-oriented exchange-traded fund (ETF). It holds more than 300 stocks, many of them high-powered tech stocks. Why look for a needle when you can buy the haystack? 10 stocks we like better than Vanguard Index Funds - Vanguard Growth ETF › If you're in the market for a compelling growth stock to invest in before 2025 ends, I'd like to suggest the Vanguard Growth ETF (NYSEMKT: VUG). It's not a standard common stock, though. It's an exchange-traded fund (ETF): a mutu ...
Karat Packaging: Undervalued Growth Opportunity With 7.5% Dividend Yield
Seeking Alpha· 2025-09-22 05:39
市场分析 - 当前股票市场环境下越来越难以找到价格合理的成长股 [1] - 标普500指数(SPY)作为市场代表性指数其当前交易价格水平受到关注 [1] 研究方法论 - 采用价值导向的投资方法 重点识别符合长期成功标准的企业 [1] - 投资理念受到沃伦·巴菲特 查理·芒格和沃尔特·施洛斯等投资大师的影响 [1] 研究覆盖范围 - 市场分析和宏观经济趋势研究 [1] - 大型蓝筹公司分析 [1] - 机构投资者通常回避的深度低估的微型股和小型股 [1] - 科技行业和市场新闻跟踪 [1]
Is Urban Outfitters (URBN) a Solid Growth Stock? 3 Reasons to Think "Yes"
ZACKS· 2025-09-19 17:46
核心观点 - 成长型股票具有高增长潜力但伴随高风险 寻找优质成长股需借助专业评分系统[1][2] - Urban Outfitters(URBN)同时具备Zacks成长评分A级和Zacks评级第2级(买入) 被系统推荐为优质成长股[2][10][11] 盈利增长 - 公司历史每股收益(EPS)增长率为49.2% 远超行业水平[5] - 今年预期EPS增长27.6% 显著超越行业平均的9.9%增长率[5] 现金流增长 - 当前年度现金流同比增长22% 优于多数同业公司[6] - 过去3-5年年度化现金流增长率达9.1% 高于行业平均的6.2%[7] - 行业平均现金流增长率为-3.2% 公司表现显著优于行业[6] 盈利预测修正 - 当前年度盈利预测获上调 过去一个月Zacks共识预期大幅提升4.8%[9] - 盈利预测修正趋势与短期股价走势存在强相关性[8] 评级与评分 - 公司获得Zacks成长评分A级 基于多项成长因素评估[10] - 综合评级为Zacks第2级(买入) 具备超额收益潜力[10][11]
Lemonade Stock: New Reinsurance Contracts Position This Company To Soar (NYSE:LMND)
Seeking Alpha· 2025-09-19 05:55
投资策略 - 在标普500指数持续创新高背景下 倾向于通过不太明显的中小盘股保持成长股敞口 [1] - 认为市场顶部交易已过于拥挤 大型股可能面临压力 [1] 分析师背景 - 拥有华尔街科技公司覆盖和硅谷工作经验的双重背景 [1] - 担任多家种子轮初创公司外部顾问 接触众多行业前沿主题 [1] - 自2017年起定期为Seeking Alpha供稿 观点被多家网络媒体引用 [1]
Lemonade: New Reinsurance Contracts Position This Company To Soar
Seeking Alpha· 2025-09-19 05:55
With the S&P 500 continuing to soar to new heights, I continue to favor retaining my exposure in growth stocks through less obvious small- and mid-cap stocks. In my view, the top of the market has become a very crowded trade in stocks likeWith combined experience of covering technology companies on Wall Street and working in Silicon Valley, and serving as an outside adviser to several seed-round startups, Gary Alexander has exposure to many of the themes shaping the industry today. He has been a regular con ...
Eli Lilly: New Orforglipron Data In Focus As Commercial Business Outperforms
Seeking Alpha· 2025-09-17 18:25
I publish my best ideas and top coverage on the Growth Stock Forum . If you're interested in finding great growth stocks, with a focus on biotech, consider signing up. We focus on attractive risk/reward situations and track each of our portfolio and watchlist stocks closely. To receive e-mail notifications for my public articles and blogs, please click the follow button . And to go deeper, sign up for Growth Stock Forum.He leads the investing group Growth Stock Forum which features: a model portfolio of 15- ...
Genmab: A Matter Of Time
Seeking Alpha· 2025-09-12 10:15
投资平台服务 - 平台专注于增长型股票和生物科技股票的投资机会 提供具有吸引力的风险回报比的投资组合和观察名单 并密切跟踪这些股票的表现 [1] - 平台提供包含15至20只股票且定期更新的模型投资组合 以及包含最多10只预期当年表现优异股票的优选名单 [2] - 平台提供针对短期和中期市场波动的交易策略 并设有社区聊天功能供投资者交流和提问 [2] 分析师持仓披露 - 分析师通过股票持有、期权或其他衍生品方式对GMAB公司持有长期多头头寸 [3]